Xylem shares have fallen 23.3% over the past year, which puts the current US$107.60 price under a different kind of spotlight. The immediate question for investors is whether that level still lines up with the cash flows the business is expected to generate.
For investors, the debate is whether Xylem's current market value is adequately backed by the cash flows implied by a Discounted Cash Flow (DCF) view.
If you are weighing whether Xylem's recent 23.3% one year share price decline is justified by its cash flows, it can help to compare that picture with other companies screened for 29 high quality undervalued stocks
The Discounted Cash Flow (DCF) model here is built around the cash Xylem is expected to generate for shareholders over time. Over the latest twelve months, the business produced roughly $940.2 million of free cash flow, which gives the analysis a solid current cash base rather than a purely theoretical forecast.
Analysts then project that free cash flow rises into the future, reaching into the mid single digit billions in aggregate over the coming decade, with growth that tapers rather than staying aggressive. That pattern fits a mature infrastructure player where cash generation is a key attraction, even if reported earnings move around from year to year. Based on these inputs, the DCF projections put Xylem's estimated intrinsic value substantially above the current share price of $107.60, so the model suggests the recent price reset may not fully reflect the cash being modelled. Find out what Xylem could be worth using our Discounted Cash Flow (DCF) estimate.
Narratives for Xylem pick up where the DCF puzzle leaves off by spelling out which paths for growth, margins and earnings would need to play out for the shares to look materially higher or lower than today’s price on Simply Wall St's Community page. Each scenario ties a fair value to a particular mix of potential catalysts and risks for Xylem, so you can see over time which storyline is tracking reality.
One of the top community narratives on Xylem: 30% undervalued
"Bullish analysts see Xylem as a direct beneficiary of rising AI related data center water needs, arguing that water is an underappreciated constraint..."
Discover why this Narrative puts Xylem at 30% undervalued.
Cash flows and price tell only part of the story for Xylem, since the decisions come from the boardroom and the pay packets that guide those choices. See who runs Xylem and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com